Literature DB >> 30218565

The Polish adaptation of the Life Events Checklist (LEC-5) for PTSD criteria from DSM-5.

Marcin Rzeszutek1, Maja Lis-Turlejska2, Hanna Palich3, Szymon Szumiał4.   

Abstract

OBJECTIVES: The aim of the study was the Polish adaptation of the Life Events Checklist (LEC-5), which is used to assess individual's traumatic events exposure for posttraumatic stress disorder (PTSD) criteria from DSM-5.
METHODS: The study was conducted on 172 students of the University of Finance and Management in Warsaw, i.e., 68 women and 104 men, at the age between 17 and 49 (M = 22.74; SD = 6.80). Reliability of LEC-5 was measured by the absolute stability method. Two repeated measurements with two week interval were conducted on the sample of 40 students of the University of Finance and Management. Validity of LEC-5 was checked by the correlational analysis between the LEC-5 scales and the PTSD Diagnostic Scale for DSM-5 (PDS-5) and the Impact of Events Scale (IES) on the whole 172 sample of students.
RESULTS: The magnitude of interclass correlation coefficients for all LEC-5 scales and high values of Cohen's kappa coefficients proved a high reliability of this tool. Significant correlations between all LEC-5 scales and PDS-5 and IES scales were also obtained, which proved satisfactory validity of LEC-5.
CONCLUSIONS: Obtained empirical results proved satisfying psychometric properties of LEC-5.

Entities:  

Keywords:  LEC-5 – Polish version; posttraumatic stress disorder (PTSD); traumatic events

Mesh:

Year:  2018        PMID: 30218565     DOI: 10.12740/PP/OnlineFirst/69218

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  1 in total

1.  The Predictive Utility of Trauma Subtypes in the Assessment of Mental Health Outcomes for Persons Resettled as Refugees.

Authors:  Liza Marie-Emilie Hinchey; Lana Ruvolo Grasser; Bassem Saad; Kathleen Gorski; Francesca Pernice; Arash Javanbakht
Journal:  J Immigr Minor Health       Date:  2022-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.